Pular para o conteúdo principal

ETHNOS_APP

Início • Busca • Periódicos • Lista 0

Marguerite Timité‐Konan

Dados Biográficos

ID7801839
NOMEMarguerite Timité‐Konan
PRENOMESMarguerite
SOBRENOMETimité‐Konan
ASSINATURAKONAN M T
AFILIAÇÕESCentre Hospitalier Universitaire de Yopougon
VERIFICADONão
TOTAL DE OBRAS2
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR2
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2008
ANO MAIS RECENTE DE PUBLICAÇÃO2014
ÍNDICE H0
  • Acceptabilité du test VIH proposé aux nourrissons dans les services pédiatriques, en Côte d'Ivoire,Significations pour la couverture du diagnostic pédiatrique

    Open Access•Maxime Oga, Hermann Brou et al.•ARTICLE•SAHARA-J Journal of Social…•2014•Referências: 7

    PROBLEM: HIV testing in children had rarely been a central concern for researchers. When pediatric tracking retained the attention, it was more to inform on the diagnosis tools' performances rather than the fact the pediatric test can be accepted or refused. This article highlights the parents' reasons which explain why pediatric HIV test is accepted or refused. OBJECTIVE: To study among parents, the explanatory factors of the acceptability of pe…

  • Month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire

    Open Access•Jérôme Harambat, Patricia Fassinou et al.•ARTICLE•BMC Public Health•2008

    Early cotrimoxazole from 6 weeks of age in HIV-infected infants seemed to reduce probability of severe events but the study lacked statistical power to prove this. Even with systematic cotrimoxazole prophylaxis, infant morbidity and mortality remained high pointing towards a need for early pediatric HIV-diagnosis and antiretroviral treatment in Africa

Sem obras proeminentes nesta página.

  • Month occurrence of severe events among early diagnosed HIV-infected children before antiretroviral therapy in Abidjan, Côte d'Ivoire

    Open Access•Jérôme Harambat, Patricia Fassinou et al.•ARTICLE•BMC Public Health•2008

    Early cotrimoxazole from 6 weeks of age in HIV-infected infants seemed to reduce probability of severe events but the study lacked statistical power to prove this. Even with systematic cotrimoxazole prophylaxis, infant morbidity and mortality remained high pointing towards a need for early pediatric HIV-diagnosis and antiretroviral treatment in Africa

  • Acceptabilité du test VIH proposé aux nourrissons dans les services pédiatriques, en Côte d'Ivoire,Significations pour la couverture du diagnostic pédiatrique

    Open Access•Maxime Oga, Hermann Brou et al.•ARTICLE•SAHARA-J Journal of Social…•2014•Referências: 7

    PROBLEM: HIV testing in children had rarely been a central concern for researchers. When pediatric tracking retained the attention, it was more to inform on the diagnosis tools' performances rather than the fact the pediatric test can be accepted or refused. This article highlights the parents' reasons which explain why pediatric HIV test is accepted or refused. OBJECTIVE: To study among parents, the explanatory factors of the acceptability of pe…

HIV Research and Treatment (2 obras) · HIV/AIDS Research and Interventions (2 obras) · Medicine (2 obras) · Pediatrics (2 obras) · Adolescent Sexual and Reproductive Health (1 obras) · Cohort (1 obras) · Cohort study (1 obras) · Confidence interval (1 obras) · Family medicine (1 obras) · Health facility (1 obras)

Ethnos_APP • Projeto Open Source • Licença MIT • Frontend v2.0.0 • Privacidade e Cookies • Documentação da API: api.ethnos.app/docs • Código da API: GitHub • DOI: 10.5281/zenodo.17049435 • Código do Frontend: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae